Diabetes Type 2

>

Latest News

Remission from Type 2 Diabetes via Lifestyle Intervention Reduces Risk for CVD, CKD / Image credit: ©PH-HY/AdobeStock
Remission from Type 2 Diabetes via Lifestyle Intervention Reduces Risk for CVD, CKD

March 27th 2024

Longer duration of remission was associated with a greater reduction in CKD and CVD risk, according to a post hoc analysis of the Look AHEAD study.

Lanifibranor Plus Empagliflozin Effective in T2D, MASH: Proof-of-Concept Ph2 Findings / image credit organs:©marina_ua/stock.adobe.com
Lanifibranor Plus Empagliflozin Effective in T2D, MASH: Proof-of-Concept Ph2 Findings

March 20th 2024

Early Detection of CKD Progression in Primary Care: Daily Dose / image credit: ©New Africa/AdobeStock
Early Detection of CKD Progression in Primary Care: Daily Dose

March 12th 2024

Semaglutide Lowers CKD-Related Events in Persons with T2D, CKD: Daily Dose / image credit: ©New Africa/AdobeStock
Semaglutide Lowers CKD-Related Events in Persons with T2D, CKD: Daily Dose

March 11th 2024

Real-World Studies Show Significant HbA1c Reductions with GLP-1 RA and Freestyle Libre CGM Used Together / image credit CGM device: ©yurri/stock.adobe.com
Real-World Studies Show Significant HbA1c Reductions with GLP-1 RA and Freestyle Libre CGM Used Together

March 6th 2024

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.